Doxorubicin inhibits PD-L1 expression by enhancing TTP-mediated decay of PD-L1 mRNA in cancer cells.
Kim DJ, Jang JH, Ham SY, Choi SH, Park SS, Jeong SY, Kim BC, Jeon DY, Lee BJ, Ko BK, Park JW, Cho WJ.
Kim DJ, et al. Among authors: park ss, park jw.
Biochem Biophys Res Commun. 2020 Feb 5;522(2):402-407. doi: 10.1016/j.bbrc.2019.11.106. Epub 2019 Nov 23.
Biochem Biophys Res Commun. 2020.
PMID: 31767150